#ozempic

[ follow ]
fromwww.npr.org
1 day ago

Restrictions on obesity drug coverage force patients to pivot

I was devastated. I had been able to get Zepbound for a $30 monthly copay and had lost 50 pounds in a year. The drug helped me focus on being a new mom and gaining strength at the gym, not just counting calories burned.
US news
#glp-1-medications
Medicine
fromScienceDaily
1 month ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Wellness
fromPsychology Today
1 month ago

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.
Alternative medicine
fromFast Company
6 days ago

With GLP1 drug ads everywhere, here's what to know to safely buy them online

GLP-1 medications for weight loss are increasingly advertised, raising concerns about safety and the rise of unregulated alternatives.
Medicine
fromPsychology Today
2 weeks ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.
Medicine
fromScienceDaily
1 month ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Wellness
fromPsychology Today
1 month ago

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.
Wellness
fromIndependent
5 days ago

Katriona O'Sullivan: 'A lot of my friends have had gastric sleeves. They're on Ozempic. They've had their face done, their arse done. If you look at the more educated woman, it's very different - it looks like wellness'

Katriona O'Sullivan discusses her experiences with body image, sexual abuse, and the impact of diet culture on her life.
#weight-loss
Medicine
fromScienceDaily
1 week ago

Stanford scientists discover "natural Ozempic" without side effects

A newly discovered molecule, BRP, reduces appetite and promotes fat loss without the side effects of Ozempic.
Medicine
fromwww.bbc.com
2 weeks ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
Medicine
fromABC7 New York
3 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
Medicine
fromScienceDaily
1 week ago

Stanford scientists discover "natural Ozempic" without side effects

A newly discovered molecule, BRP, reduces appetite and promotes fat loss without the side effects of Ozempic.
Medicine
fromwww.bbc.com
2 weeks ago

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.
Medicine
fromABC7 New York
3 weeks ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
#glp-1
Medicine
fromFast Company
2 weeks ago

A new weight loss pill is here and it could reshape the GLP-1 market

Eli Lilly's GLP-1 pill, Foundayo, approved for obesity treatment, shows significant weight loss results and aims for affordability.
Medicine
fromThe Atlantic
1 week ago

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.
SF food
fromwww.npr.org
1 month ago

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.
fromwww.npr.org
3 weeks ago

The FDA approves a new obesity pill, giving patients another option

We've created a small molecule chemical which gets in your body very well. It can mimic the effects of the peptide and can be taken more conveniently any time of day without any food or water restrictions.
US news
#glp-1-drugs
fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

fromFuturism
1 month ago
Medicine

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Medicine
fromFuturism
1 month ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
Medicine
fromwww.scientificamerican.com
2 weeks ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
Food & drink
fromFortune
1 month ago

Ozempic mania has even Olive Garden and The Cheesecake Factory cutting back on portion sizes | Fortune

Restaurants are introducing smaller, less expensive portion menus to meet diverse customer needs including budget constraints, health goals, and changing eating patterns.
#obesity
Medicine
fromWIRED
3 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromWIRED
3 weeks ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromwww.theguardian.com
3 weeks ago

NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes

NHS England will provide weight-loss drugs to over 1 million people to reduce heart attack and stroke risks.
fromIndependent
2 months ago

'I haven't told many people' - new mums are turning to weight-loss drugs like Ozempic after having a baby, but there's still stigma

The months before and after pregnancy can be extremely challenging for women, both mentally and physically, and some turn to GLP-1 medications to cope with weight gain. Here, Kirsty Blake Knox speaks to Irish mothers about their experiences on the drugs and the stigma surrounding them Ciara*, from Dublin, became a first-time mother at the age of 39. She knew she wanted a
Women
#novo-nordisk
#weight-loss-drugs
fromBBC
2 months ago
Public health

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

fromBBC
2 months ago
Public health

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

fromBusiness Insider
2 months ago

People are using Ozempic to drink less. We already have FDA-approved drugs for that.

To some extent, Americans are talking about alcohol more than ever. We're having open conversations about the negative health impacts of drinking. People are consuming less booze overall and examining strategies to moderate, even as each drink packs more punch. There is one aspect of alcohol we're still not talking about: addiction, and, more precisely, the medical treatments available to combat it. What's even odder - your doctor may not know much about them, either.
Public health
Food & drink
fromMail Online
2 months ago

Natural Ozempic: Chia seeds can reduce appetite, study shows

Chia seeds, high in ALA omega-3s and complete protein, may protect brain and body from inflammation and metabolic damage caused by high-fat, high-sugar ultra-processed diets.
Public health
fromIndependent
2 months ago

Revealed: The massive HSE spend on weight-loss jabs like Ozempic - and which area is availing of the drugs most

Public healthcare spending on Ozempic and similar weight-loss injections exceeded €200 million in under three years, funded by taxpayers.
Medicine
fromwww.scientificamerican.com
1 month ago

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.
#glp-1-receptor-agonists
Medicine
fromwww.theguardian.com
1 month ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Medicine
fromwww.theguardian.com
1 month ago

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.
Medicine
fromwww.theguardian.com
1 month ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Medicine
fromwww.theguardian.com
1 month ago

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.
Medicine
fromwww.scientificamerican.com
1 month ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
Medicine
fromFortune
1 month ago

Health startup Noom is now adding weight loss injectables to its offerings, says 'outcomes are so much better' | Fortune

Noom launches Noom Med, combining GLP-1 obesity drugs like Wegovy with behavioral coaching for $120 monthly, joining competitors capitalizing on highly effective weight-loss medications.
#glp-1-agonists
fromwww.theguardian.com
1 month ago

Weight-loss jab could be made for $3 a month, study finds

New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about 2.35) for a monthly dose in its injectable form. Newer formulations, taken as a pill rather than an injection, could be made for about $16 a month.
Medicine
[ Load more ]